Brief: Concord Biotech Sept-Quarter Consol Net Profit At 957.4 Million Rupees
11/11/2024 07:24
Nov 11 (Reuters) - Concord Biotech Ltd CONB.NS :
* CONCORD BIOTECH SEPT-QUARTER CONSOL NET PROFIT 957.4
MILLION
RUPEES
* CONCORD BIOTECH SEPT-QUARTER CONSOL REVENUE FROM
OPERATIONS 3.1
BILLION RUPEES
Source text: ID:nBSECTmNG
Further company coverage: CONB.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval